gefitinib has been researched along with ag 1295 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (ag 1295) | Trials (ag 1295) | Recent Studies (post-2010) (ag 1295) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 17 | 0 | 4 |
| Protein | Taxonomy | gefitinib (IC50) | ag 1295 (IC50) |
|---|---|---|---|
| Dihydrofolate reductase | Homo sapiens (human) | 6.2 | |
| Dihydrofolate reductase | Mus musculus (house mouse) | 6.2 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 6.2 | |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | 3.7333 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 6.26 | |
| Dihydrofolate reductase | Pneumocystis carinii | 6.2 | |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | 2.9 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 6.2 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 1.1 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for gefitinib and ag 1295
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |